-
2
-
-
0018416379
-
Genetic heterogeneity in osteogenesis imperfecta
-
Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101-116.
-
(1979)
J Med Genet.
, vol.16
, pp. 101-116
-
-
Sillence, D.O.1
Senn, A.2
Danks, D.M.3
-
3
-
-
84874106867
-
Femoral geometric parameters and bmd measurements by dxa in adult patients with different types of osteogenesis imperfecta
-
Kocijan R, Muschitz C, Fratzl-Zelman N, et al. Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta. Skeletal Radiol. 42:187-194.
-
Skeletal Radiol.
, vol.42
, pp. 187-194
-
-
Kocijan, R.1
Muschitz, C.2
Fratzl-Zelman, N.3
-
5
-
-
22844445934
-
Sost is a ligand for lrp5/lrp6 and a wnt signaling inhibitor
-
Semenov M, Tamai K, He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem. 2005;280:26770-26775.
-
(2005)
J Biol Chem.
, vol.280
, pp. 26770-26775
-
-
Semenov, M.1
Tamai, K.2
He, X.3
-
6
-
-
4644227529
-
Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis
-
Ohyama Y, Nifuji A, Maeda Y, Amagasa T, Noda M. Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis. Endocrinology. 2004;145:4685-4692.
-
(2004)
Endocrinology.
, vol.145
, pp. 4685-4692
-
-
Ohyama, Y.1
Nifuji, A.2
Maeda, Y.3
Amagasa, T.4
Noda, M.5
-
7
-
-
77957846460
-
Relation of age, gender, and bone mass to circulating sclerostin levels in women and men
-
Modder UI, Hoey KA, Amin S, et al. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res. 2011;26:373-379.
-
(2011)
J Bone Miner Res.
, vol.26
, pp. 373-379
-
-
Modder, U.I.1
Hoey, K.A.2
Amin, S.3
-
8
-
-
84855474270
-
Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults
-
Amrein K, Amrein S, Drexler C, et al. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab. 2012; 97:148-154.
-
(2012)
J Clin Endocrinol Metab.
, vol.97
, pp. 148-154
-
-
Amrein, K.1
Amrein, S.2
Drexler, C.3
-
9
-
-
77952771209
-
Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss
-
Gaudio A, Pennisi P, Bratengeier C, et al. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab. 2010;95:2248-2253.
-
(2010)
J Clin Endocrinol Metab.
, vol.95
, pp. 2248-2253
-
-
Gaudio, A.1
Pennisi, P.2
Bratengeier, C.3
-
11
-
-
81855184668
-
Determinants of serum sclerostin in healthy pre- and postmenopausal women
-
Ardawi MS, Al-Kadi HA, Rouzi AA, Qari MH. Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res. 2011;26:2812-2822.
-
(2011)
J Bone Miner Res.
, vol.26
, pp. 2812-2822
-
-
Ardawi, M.S.1
Al-Kadi, H.A.2
Rouzi, A.A.3
Qari, M.H.4
-
12
-
-
84873726062
-
Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: The ofely study
-
Garnero P, Sornay-Rendu E, Munoz F, Borel O, Chapurlat RD. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int. 2013; 24:489-494.
-
(2013)
Osteoporos Int.
, vol.24
, pp. 489-494
-
-
Garnero, P.1
Sornay-Rendu, E.2
Munoz, F.3
Borel, O.4
Chapurlat, R.D.5
-
13
-
-
84875186616
-
Lower fracture risk in older men with higher sclerostin concentration-A prospective analysis from the minos study
-
Szulc P, Bertholon C, Borel O, Marchand F, Chapurlat R. Lower fracture risk in older men with higher sclerostin concentration-A prospective analysis from the MINOS study. J Bone Miner Res. 2013;28(4):855-864.
-
(2013)
J Bone Miner Res.
, vol.28
, Issue.4
, pp. 855-864
-
-
Szulc, P.1
Bertholon, C.2
Borel, O.3
Marchand, F.4
Chapurlat, R.5
-
14
-
-
84861985326
-
Serum sclerostin and risk of hip fracture in older caucasian women
-
Arasu A, Cawthon PM, et al. Serum sclerostin and risk of hip fracture in older Caucasian women. J Clin Endocrinol Metab. 2012; 97:2027-2032.
-
(2012)
J Clin Endocrinol Metab.
, vol.97
, pp. 2027-2032
-
-
Arasu, A.1
Cawthon, P.M.2
-
15
-
-
84869390060
-
High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: The center of excellence for osteoporosis research study
-
Ardawi MS, Rouzi AA, Al-Sibiani SA, Al-Senani NS, Qari MH, Mousa SA. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the center of excellence for osteoporosis research study. J Bone Miner Res. 2012;27:2592-2602.
-
(2012)
J Bone Miner Res.
, vol.27
, pp. 2592-2602
-
-
Ardawi, M.S.1
Rouzi, A.A.2
Al-Sibiani, S.A.3
Al-Senani, N.S.4
Qari, M.H.5
Mousa, S.A.6
-
16
-
-
84860128591
-
Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south chinese postmenopausal women
-
Sheng Z, Tong D,OuY, et al. Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women. Clin Endocrinol (Oxf). 2012;76: 797-801.
-
(2012)
Clin Endocrinol (Oxf).
, vol.76
, pp. 797-801
-
-
Sheng, Z.1
Tong, D.2
Ou, Y.3
-
17
-
-
65549152230
-
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis
-
Li X, Ominsky MS, Warmington KS, et al. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res. 2009; 24:578-588.
-
(2009)
J Bone Miner Res.
, vol.24
, pp. 578-588
-
-
Li, X.1
Ominsky, M.S.2
Warmington, K.S.3
-
18
-
-
84867336111
-
Newtherapeutic targets for osteoporosis: Beyond denosumab
-
Lim V, Clarke BL.Newtherapeutic targets for osteoporosis: beyond denosumab. Maturitas. 2012;73:269-272.
-
(2012)
Maturitas.
, vol.73
, pp. 269-272
-
-
Lim, V.1
Clarke, B.L.2
-
19
-
-
84872844733
-
Sclerostin antibody improves skeletal parameters in a brtl/- mouse model of osteogenesis imperfecta
-
Sinder BP, Eddy MM, Ominsky MS, Caird MS, Marini JC, Kozloff KM. Sclerostin antibody improves skeletal parameters in a Brtl/- mouse model of osteogenesis imperfecta. J Bone Miner Res. 2013; 28:73-80.
-
(2013)
J Bone Miner Res.
, vol.28
, pp. 73-80
-
-
Sinder, B.P.1
Eddy, M.M.2
Ominsky, M.S.3
Caird, M.S.4
Marini, J.C.5
Kozloff, K.M.6
-
20
-
-
84857440881
-
Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women-The six-month effect of risedronate and teriparatide
-
Polyzos SA, Anastasilakis AD, Bratengeier C, Woloszczuk W, Papatheodorou A, Terpos E. Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women-The six-month effect of risedronate and teriparatide. Osteoporos Int. 2012;23:1171-1176.
-
(2012)
Osteoporos Int.
, vol.23
, pp. 1171-1176
-
-
Polyzos, S.A.1
Anastasilakis, A.D.2
Bratengeier, C.3
Woloszczuk, W.4
Papatheodorou, A.5
Terpos, E.6
-
21
-
-
84880148878
-
The association between insulin-like growth factor i and bone turnover markers in the general adult population
-
Niemann I, Hannemann A, NauckM,et al. The association between insulin-like growth factor I and bone turnover markers in the general adult population. Bone. 2013;56:184-190.
-
(2013)
Bone.
, vol.56
, pp. 184-190
-
-
Niemann, I.1
Hannemann, A.2
Nauck, M.3
-
22
-
-
84863710246
-
Evaluation of ids-isys intact parathyroid hormone (ipth) and comparison to siemens advia centaur ipth assay in chronic renal failure patients and in controls
-
Koivula MK, Laitinen P, Risteli J. Evaluation of IDS-iSYS intact parathyroid hormone (iPTH) and comparison to Siemens Advia Centaur iPTH assay in chronic renal failure patients and in controls. Clin Lab. 2012;58:403-410.
-
(2012)
Clin Lab.
, vol.58
, pp. 403-410
-
-
Koivula, M.K.1
Laitinen, P.2
Risteli, J.3
-
23
-
-
84876544339
-
Four automated 25-oh total vitamin d immunoassays and commercial liquid chromatography tandem-mass spectrometry in finnish population
-
Koivula MK, Matinlassi N, Laitinen P, Risteli J. Four automated 25-OH total vitamin D immunoassays and commercial liquid chromatography tandem-mass spectrometry in Finnish population. Clin Lab. 2013;59:397-405.
-
(2013)
Clin Lab.
, vol.59
, pp. 397-405
-
-
Koivula, M.K.1
Matinlassi, N.2
Laitinen, P.3
Risteli, J.4
-
24
-
-
1642443472
-
Performance evaluation of automated assays for -crosslaps, n-mid-osteocalcin and intact parathyroid hormone (biorose multicenter study
-
Schmidt-Gayk H, Spanuth E, Kotting J, et al. Performance evaluation of automated assays for -CrossLaps, N-MID-Osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study). Clin Chem Lab Med. 2004;42:90-95.
-
(2004)
Clin Chem Lab Med.
, vol.42
, pp. 90-95
-
-
Schmidt-Gayk, H.1
Spanuth, E.2
Kotting, J.3
-
25
-
-
78651076679
-
In vivo precision of the ge lunar idxa densitometer for the measurement of total body composition and fat distribution in adults
-
Hind K, Oldroyd B, Truscott JG. In vivo precision of the GE Lunar iDXA densitometer for the measurement of total body composition and fat distribution in adults. Eur J Clin Nutr. 2011;65:140-142.
-
(2011)
Eur J Clin Nutr.
, vol.65
, pp. 140-142
-
-
Hind, K.1
Oldroyd, B.2
Truscott, J.G.3
-
26
-
-
0034022769
-
Static and dynamic bone histomorphometry in children with osteogenesis imperfecta
-
Rauch F, Travers R, Parfitt AM, Glorieux FH. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone. 2000;26:581-589.
-
(2000)
Bone.
, vol.26
, pp. 581-589
-
-
Rauch, F.1
Travers, R.2
Parfitt, A.M.3
Glorieux, F.H.4
-
27
-
-
56749095463
-
Cellular mechanism of decreased bone in brtl mouse model of oi: Imbalance of decreased osteoblast function and increased osteoclasts and their precursors
-
Uveges TE, Collin-Osdoby P, Cabral WA, et al. Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors. J Bone Miner Res. 2008;23:1983-1994.
-
(2008)
J Bone Miner Res.
, vol.23
, pp. 1983-1994
-
-
Uveges, T.E.1
Collin-Osdoby, P.2
Cabral, W.A.3
-
28
-
-
33746088003
-
Bone tissue in osteogenesis imperfecta: Light and electron microscopic studies]
-
Osipenkova-Vichtomova TK. [Bone tissue in osteogenesis imperfecta: light and electron microscopic studies]. Arkhiv Patologii. 2006;68:20-25.
-
(2006)
Arkhiv Patologii.
, vol.68
, pp. 20-25
-
-
Osipenkova-Vichtomova, T.K.1
-
29
-
-
26844469532
-
Musculoskeletal manifestations of mild osteogenesis imperfecta in the adult
-
McKiernan FE. Musculoskeletal manifestations of mild osteogenesis imperfecta in the adult. Osteoporos Int. 2005;16:1698-1702.
-
(2005)
Osteoporos Int.
, vol.16
, pp. 1698-1702
-
-
McKiernan, F.E.1
-
30
-
-
84890155703
-
Functioning and quality of life in adults with mild-To-moderate osteogenesis imperfecta [published online december 27, 2012]
-
doi: 10.1002/pri.1546
-
Balkefors V, Mattsson E, Pernow Y, Saaf M. Functioning and quality of life in adults with mild-To-moderate osteogenesis imperfecta [published online December 27, 2012]. Physiother Res Int. doi: 10.1002/pri.1546.
-
Physiother Res Int
-
-
Balkefors, V.1
Mattsson, E.2
Pernow, Y.3
Saaf, M.4
-
31
-
-
2942525923
-
Bone turnover markers in patients with osteogenesis imperfecta
-
Braga V, Gatti D, Rossini M, Colapietro F, Battaglia E, Viapiana O, Adami S. Bone turnover markers in patients with osteogenesis imperfecta. Bone. 2004;34:1013-1016.
-
(2004)
Bone.
, vol.34
, pp. 1013-1016
-
-
Braga, V.1
Gatti, D.2
Rossini, M.3
Colapietro, F.4
Battaglia, E.5
Viapiana, O.6
Adami, S.7
-
32
-
-
69549096354
-
Osteogenesis imperfecta: Recent findings shed new light on this once well-understood condition
-
Basel D, Steiner RD. Osteogenesis imperfecta: recent findings shed new light on this once well-understood condition. GenetMed. 2009; 11:375-385.
-
(2009)
GenetMed.
, vol.11
, pp. 375-385
-
-
Basel, D.1
Steiner, R.D.2
-
33
-
-
34249866221
-
Bone formation markers in adults with mild osteogenesis imperfecta
-
Cundy T, Horne A, Bolland M, Gamble G, Davidson J. Bone formation markers in adults with mild osteogenesis imperfecta. Clin Chem. 2007;53:1109-1114.
-
(2007)
Clin Chem.
, vol.53
, pp. 1109-1114
-
-
Cundy, T.1
Horne, A.2
Bolland, M.3
Gamble, G.4
Davidson, J.5
-
34
-
-
59649092309
-
Bone turnover and type i collagen c-Telopeptide isomerization in adult osteogenesis imperfecta: Associations with collagen gene mutations
-
Garnero P, Schott AM, Prockop D, Chevrel G. Bone turnover and type I collagen C-Telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations. Bone. 2009; 44:461-466.
-
(2009)
Bone.
, vol.44
, pp. 461-466
-
-
Garnero, P.1
Schott, A.M.2
Prockop, D.3
Chevrel, G.4
-
35
-
-
70449345629
-
Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of pinp with fracture reduction in postmenopausal women with osteoporosis
-
Delmas PD, Munoz F, Black DM, et al. Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis. J Bone Miner Res. 2009;24:1544-1551.
-
(2009)
J Bone Miner Res.
, vol.24
, pp. 1544-1551
-
-
Delmas, P.D.1
Munoz, F.2
Black, D.M.3
-
36
-
-
33847734705
-
Prolonged bisphosphonate release after treatment in children
-
Papapoulos SE, Cremers SC. Prolonged bisphosphonate release after treatment in children. N Engl J Med. 2007;356:1075-1076.
-
(2007)
N Engl J Med.
, vol.356
, pp. 1075-1076
-
-
Papapoulos, S.E.1
Cremers, S.C.2
-
37
-
-
0036250837
-
Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta
-
Astrom E, Soderhall S. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child. 2002;86:356-364.
-
(2002)
Arch Dis Child.
, vol.86
, pp. 356-364
-
-
Astrom, E.1
Soderhall, S.2
-
38
-
-
84857366513
-
Risedronate in adults with osteogenesis imperfecta type i: Increased bone mineral density and decreased bone turnover, but high fracture rate persists
-
Bradbury LA, Barlow S, Geoghegan F, et al. Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists. Osteoporos Int. 2012;23:285-294.
-
(2012)
Osteoporos Int.
, vol.23
, pp. 285-294
-
-
Bradbury, L.A.1
Barlow, S.2
Geoghegan, F.3
-
39
-
-
84861723097
-
Long-Term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women
-
Chung YE, Lee SH, Lee SY, et al. Long-Term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women. Osteoporos Int. 2012;23:1235-1243.
-
(2012)
Osteoporos Int.
, vol.23
, pp. 1235-1243
-
-
Chung, Y.E.1
Lee, S.H.2
Lee, S.Y.3
-
40
-
-
84856963771
-
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin
-
Gatti D, Viapiana O, Adami S, Idolazzi L, Fracassi E, Rossini M. Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. Bone. 2012;50:739-742.
-
(2012)
Bone.
, vol.50
, pp. 739-742
-
-
Gatti, D.1
Viapiana, O.2
Adami, S.3
Idolazzi, L.4
Fracassi, E.5
Rossini, M.6
-
41
-
-
41949089764
-
Mechanical stimulation of bone in vivo reduces osteocyte expression of sost/sclerostin
-
Robling AG, Niziolek PJ, Baldridge LA, et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem. 2008;283:5866-5875.
-
(2008)
J Biol Chem.
, vol.283
, pp. 5866-5875
-
-
Robling, A.G.1
Niziolek, P.J.2
Baldridge, L.A.3
-
42
-
-
84861316084
-
Bone geometry, density, and microarchitecture in the distal radius and tibia in adults with osteogenesis imperfecta type i assessed by high-resolution pqct
-
Folkestad L, Hald JD, Hansen S, Gram J, Langdahl B, Abrahamsen B, Brixen K. Bone geometry, density, and microarchitecture in the distal radius and tibia in adults with osteogenesis imperfecta type I assessed by high-resolution pQCT. J Bone Miner Res. 2012;27:1405-1412.
-
(2012)
J Bone Miner Res.
, vol.27
, pp. 1405-1412
-
-
Folkestad, L.1
Hald, J.D.2
Hansen, S.3
Gram, J.4
Langdahl, B.5
Abrahamsen, B.6
Brixen, K.7
|